デジタル薬局市場:医薬品(Rx、OTC)、製品(医療、パーソナルケア、ビタミン&サプリメント、糖尿病、CVD、腫瘍)、プラットフォーム(アプリ、ウェブサイト)、ビジネスモデル(Captive、フランチャイズ、Aggregator)、地域(都市、地方)- 2027年までの世界市場予測Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecasts to 2027 デジタルファーマシー市場は、2022年の965億米ドルから2027年には2119億米ドルに達し、予測期間中のCAGRは17.0%となる見通しです。この市場の成長は、COVID-19パンデミック時およびその後に、オンラインで医薬品... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーデジタルファーマシー市場は、2022年の965億米ドルから2027年には2119億米ドルに達し、予測期間中のCAGRは17.0%となる見通しです。この市場の成長は、COVID-19パンデミック時およびその後に、オンラインで医薬品を購入する消費者の嗜好が高まっていること、市場の統合やパートナーシップ、老年人口の増加などが要因となっています。しかし、臨床支援を薬剤師に依存する患者や違法薬局の増加が、予測期間中の同市場の成長を抑制すると見られています。 「一般用医薬品(OTC)市場は予測期間中に最も高い成長率を示すと予想される デジタルファーマシー市場は、薬剤の種類に基づき、処方箋医薬品と一般用医薬品に区分されます。2021年の世界のデジタルファーマシー市場では、処方箋医薬品が最大のシェアを占めています。この市場セグメントの大きなシェアは、いくつかの慢性疾患の有病率の増加や、それに伴う医薬品の需要の増加といった要因に起因するものです。 一方、店頭販売(OTC)製品セグメントは、予測期間中に最も高いCAGRで成長すると予想されます。この市場の成長は、一般用医薬品が広く入手可能で費用対効果に優れていること、またセルフメディケーションの傾向が強まっていることが主な要因となっています。 "2021年には医薬品・治療薬セグメントがtheDigital Pharmacy Marketの最大シェアを占めると予想" デジタルファーマシー市場は、ofproducts(製品)ベースで、医薬品&トリートメント、パーソナルケア製品、ビタミン&サプリメント、その他製品に区分されます。2021年の世界のデジタルファーマシー市場では、医薬品・治療薬分野が最大のシェアを占めています。 しかし、ビタミン&サプリメントセグメントは、慢性疾患の有病率の増加や複数の製品オプションの利用可能性から、予測期間中に最も高いCAGRを記録すると予想されます。 "プラットフォームにおけるアプリセグメントは、世界のデジタルファーマシー市場で最大のシェアを占めると予想される" ofplatformsに基づいて、デジタルファーマシー市場は、アプリとウェブサイトに区分されます。2021年に、アプリは、世界のデジタル薬局市場の最大のシェアを保持すると予想され、このセグメントの成長はappsoffer有利なプロモや顧客を引き付けるために割引などの要因に起因する。Webサイトプラットフォームは、ウェブサイトが提供する便利さ、プライバシー、安全性が原因で予測期間中に2番目に高いCAGRで成長すると推定されている市場の成長を促進する重要な要因です。 "2021年の世界のデジタルファーマシー市場では、ビジネスモデルのうちキャプティブsegmentamongが最大のシェアを占めた" デジタルファーマシー市場は、ofbusinessモデルに基づいて、キャプティブ、フランチャイズ、アグリゲータのビジネスモデルに区分されます。キャプティブビジネスモデルは、2021年に世界のデジタル薬局市場で最大のシェアを占め キャプティブビジネスモデルはまた、予測期間中に最高のCAGRを記録すると推定されます。キャプティブビジネスモデルの柔軟性、アクセス性、手頃な価格は、デジタルファーマシー市場のセグメント成長の主な要因です。アグリゲータービジネスモデルは、予測期間中に2番目に高いCAGRで成長すると推定されます。 "2021年、世界のデジタルファーマシー市場でUrbanareasaccounted the largest share" 地理的な範囲に基づいて、デジタルファーマシー市場は都市部と農村部に区分されます。都市部でのインターネットの普及が進んでいることから、2021年のデジタルファーマシー世界市場では、都市部が最大のシェアを占めています。 "予測期間中、北米がデジタルファーマシー市場を支配する" 2022年のデジタルファーマシー市場は、北米が最大のシェアを占めました。慢性疾患の蔓延、高齢化の急速な進展による薬剤処方数の増加、同地域における主要な市場プレイヤーの存在が、北米のデジタルファーマシー市場の成長を促進する主な要因となっています。 アジア太平洋地域は、疾病負担の増加、患者数の増加、医薬品市場の急成長により、予測期間中に最も高いCAGRを記録すると予測されます。 サプライサイドの一次面接の内訳(企業タイプ別、呼称別、地域別)。 - 企業タイプ別企業タイプ別:Tier 1 (41%)、Tier 2 (31%)、Tier 3 (28%) - 役職別Cレベル(44%)、ディレクターレベル(35%)、その他(21%) - 地域別北米 (46%)、欧州 (26%)、アジア太平洋 (18%)、中南米 (7%)、中東・アフリカ (3%) 本市場における主なプレイヤーは、CVS Health(米国)、Cigna(米国)、Optum, Inc.(UnitedHealth Group傘下)(米国)、Walgreens Co.(米国)、Walmart Inc.(米国)、Hims&Hers Health, Inc.(米国)、PharmEasy(インド)、Apollo Pharmacy(インド)、DocMorris(オランダ)、Giant Eagle Inc(米国)、LloydsPharmacy(英国)、Shop-apotheke.com(オランダ)、Tata 1mg(インド)、Netmeds.com(インド)、HealthWarecy.com(インド)、HealthWarehouse, Inc(米国)、Pharmex Direct Inc(カナダ)、Apex Pharmacy(英国)、TELUS(カナダ)、RO Pharmacy(米国)、Rx Outreach(米国)、The Independent Pharmacy(英国)、Rexall Pharmacy Group ULC(カナダ)、および NorthWestPharmacy.com (カナダ)これらの企業は、デジタル薬局市場における製品提供を拡大するために製品/サービスのアップグレード、買収、提携、合意、拡張、および協力にますます焦点を合わせています。 調査範囲 - 本レポートでは、薬剤の種類、製品、プラットフォーム、ビジネスモデル、地理的範囲、地域などに基づいてtheDigital Pharmacy市場を調査しています。 - 市場成長に影響を与える要因(ドライバー、阻害要因、機会、andchallengesなど)を分析しています。 - 利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供します。 - デジタルファーマシー市場全体に対する成長動向、展望、貢献度に関してミクロ市場を調査しています。 - 主要5地域に関する市場セグメントの売上高を予測しています。 レポート購入の主なメリット 本レポートは、市場全体とサブセグメントの収益数値の最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者を支援します。本レポートは、利害関係者が競争環境を理解し、より良いビジネスの位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者がデジタル薬局市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。 目次1 INTRODUCTION 271.1 OBJECTIVES OF THE STUDY 27 1.2 MARKET DEFINITION 27 1.2.1 DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS 27 1.3 MARKET SCOPE 28 1.3.1 MARKETS COVERED 28 FIGURE 1 DIGITAL PHARMACY MARKET 28 1.3.2 YEARS CONSIDERED FOR THE STUDY 29 1.4 CURRENCY 29 1.5 LIMITATIONS 29 1.5.1 SCOPE-RELATED LIMITATIONS 29 1.6 STAKEHOLDERS 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH DATA 30 FIGURE 2 RESEARCH DESIGN 30 2.1.1 SECONDARY DATA 31 2.1.1.1 Key data from secondary sources 32 2.1.2 PRIMARY RESEARCH 32 2.1.2.1 Key industry insights 33 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34 2.2 MARKET ESTIMATION 34 2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 34 2.2.2 APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION 35 FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 36 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36 FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH 37 2.2.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION 38 FIGURE 7 DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH 38 2.2.4 GROWTH FORECAST 38 FIGURE 8 IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR 39 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39 2.3 MARKET DATA ESTIMATION AND TRIANGULATION 40 FIGURE 10 DATA TRIANGULATION METHODOLOGY 40 2.4 ASSUMPTIONS FOR THE STUDY 41 2.5 LIMITATIONS 41 2.6 RISK ASSESSMENT 42 TABLE 1 RISK ASSESSMENT: DIGITAL PHARMACY MARKET 42 3 EXECUTIVE SUMMARY 43 FIGURE 11 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION) 43 FIGURE 12 DIGITAL PHARMACY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 44 FIGURE 13 DIGITAL PHARMACY MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION) 44 FIGURE 14 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2022 VS. 2027 (USD MILLION) 45 FIGURE 15 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2022 VS. 2027 (USD MILLION) 46 FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET 47 4 PREMIUM INSIGHTS 48 4.1 DIGITAL PHARMACY MARKET OVERVIEW 48 FIGURE 17 GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH 48 4.2 DIGITAL PHARMACY MARKET, BY PRODUCT 49 FIGURE 18 MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PHARMACY MARKET IN 2021 49 4.3 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG & COUNTRY (2021) 49 FIGURE 19 PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021 49 4.4 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET 50 FIGURE 20 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 50 4.5 MARKET DYNAMICS 51 FIGURE 21 DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 4.5.1 DRIVERS 52 4.5.1.1 Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic 52 TABLE 2 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022) 52 4.5.1.2 Consolidation in the market and partnerships 53 4.5.1.3 Growing geriatric population 53 TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION) 53 4.5.2 RESTRAINTS 54 4.5.2.1 Growing number of illegal pharmacies 54 4.5.2.2 Risk of counterfeit drugs 54 4.5.2.3 Increased risk of drug abuse 55 4.5.3 OPPORTUNITIES 55 4.5.3.1 Emerging markets 55 4.5.3.2 Benefits of E-commerce 56 4.5.4 CHALLENGES 56 4.5.4.1 Challenges for patients relying on pharmacists for clinical support 56 4.5.4.2 Lack of strong national laws worldwide 57 4.5.4.3 Security and privacy concerns 58 4.6 VALUE CHAIN ANALYSIS 59 4.7 ECOSYSTEM ANALYSIS 60 4.8 PORTER’S FIVE FORCES ANALYSIS 60 TABLE 4 DIGITAL PHARMACY MARKET: PORTER’S FIVE FORCES ANALYSIS 60 4.8.1 INTENSITY OF COMPETITIVE RIVALRY 61 4.8.2 BARGAINING POWER OF SUPPLIERS 61 4.8.3 BARGAINING POWER OF BUYERS 61 4.8.4 THREAT FROM SUBSTITUTES 61 4.8.5 THREAT FROM NEW ENTRANTS 61 4.9 PRICING & REIMBURSEMENT ANALYSIS 61 TABLE 5 COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS 62 4.10 TECHNOLOGY ANALYSIS 62 4.10.1 MACHINE LEARNING 62 4.10.2 INTERNET OF THINGS 63 4.10.3 BLOCKCHAIN 63 4.10.4 CLOUD COMPUTING 63 4.11 INDUSTRY TRENDS 63 4.11.1 ONLINE PRESCRIPTION REFILL 63 4.11.2 VIRTUAL HEALTHCARE SERVICES 64 4.11.3 DIGITAL HEALTH DIAGNOSTIC TOOLS 64 4.12 KEY CONFERENCES & EVENTS IN 2021–2022 65 4.13 REGULATORY ANALYSIS 65 4.13.1 NORTH AMERICA 65 4.13.1.1 US 65 4.13.1.2 Canada 66 4.13.2 EUROPE 66 4.13.3 ASIA PACIFIC 67 4.13.4 REST OF THE WORLD 67 TABLE 6 APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE TO CONTROL MEDICINAL PRODUCT ONLINE SALES 67 4.14 CASE STUDIES 68 4.14.1 MAGENTO 2 WEB APP MODERNIZATION 68 4.14.1.1 Use Case 1: Need to Revamp Online Store 68 4.14.2 WALMART REACT NATIVE PHARMACY 69 4.14.2.1 Use Case 2: Need to Rebuild Pharmacy App 69 4.15 IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET 69 5 DIGITAL PHARMACY MARKET, BY DRUG TYPE 70 5.1 INTRODUCTION 71 TABLE 7 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 71 5.2 PRESCRIPTION MEDICINES 71 5.2.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION 71 TABLE 8 DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020–2027 (USD MILLION) 72 TABLE 9 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION) 72 TABLE 10 EUROPE: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION) 73 5.3 OVER-THE-COUNTER PRODUCTS 73 5.3.1 EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH 73 TABLE 11 DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 74 TABLE 12 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 74 TABLE 13 EUROPE: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 75 6 DIGITAL PHARMACY MARKET, BY PRODUCT 76 6.1 INTRODUCTION 77 TABLE 14 DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77 6.2 MEDICINES & TREATMENTS 77 TABLE 15 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 78 TABLE 16 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 17 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 18 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 79 TABLE 19 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 79 6.2.1 DIABETES CARE 79 6.2.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments 79 TABLE 20 DIGITAL PHARMACY MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 80 6.2.2 HEART CARE 80 6.2.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments 80 TABLE 21 DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 81 6.2.3 ONCOLOGY 81 6.2.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment 81 TABLE 22 DIGITAL PHARMACY MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 81 6.2.3.2 Other medicines & treatments 82 TABLE 23 DIGITAL PHARMACY MARKET FOR OTHER MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 82 6.3 PERSONAL CARE PRODUCTS 82 6.3.1 GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH 82 TABLE 24 DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 83 TABLE 25 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 83 TABLE 26 EUROPE: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 83 TABLE 27 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 84 6.4 VITAMINS & SUPPLEMENTS 84 6.4.1 GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH 84 TABLE 28 DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020–2027 (USD MILLION) 85 TABLE 29 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 30 EUROPE: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 31 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 86 6.5 OTHER PRODUCTS 86 TABLE 32 DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 86 TABLE 33 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 TABLE 34 EUROPE: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 TABLE 35 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 7 DIGITAL PHARMACY MARKET, BY PLATFORM 88 7.1 INTRODUCTION 89 TABLE 36 DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 89 7.2 APPS 89 7.2.1 ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL DRIVE THE DEMAND FOR APPS 89 TABLE 37 DIGITAL PHARMACY APPS MARKET, BY REGION, 2020–2027 (USD MILLION) 90 TABLE 38 NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90 TABLE 39 EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90 TABLE 40 ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91 7.3 WEBSITES 91 7.3.1 PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH 91 TABLE 41 DIGITAL PHARMACY WEBSITES MARKET, BY REGION, 2020–2027 (USD MILLION) 92 TABLE 42 NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 TABLE 43 EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 TABLE 44 ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93 8 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL 94 8.1 INTRODUCTION 95 TABLE 45 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 95 8.2 CAPTIVE 95 8.2.1 FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS— KEY FACTORS DRIVING MARKET GROWTH 95 TABLE 46 DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY REGION, 2020–2027 (USD MILLION) 96 TABLE 47 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 48 EUROPE: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 49 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 97 8.3 FRANCHISE 97 8.3.1 GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH 97 TABLE 50 DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY REGION, 2020–2027 (USD MILLION) 98 TABLE 51 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 98 TABLE 52 EUROPE: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 98 TABLE 53 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 99 8.4 AGGREGATOR 99 8.4.1 QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH 99 TABLE 54 DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY REGION, 2020–2027 (USD MILLION) 100 TABLE 55 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 100 TABLE 56 EUROPE: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 100 TABLE 57 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 101 9 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE 102 9.1 INTRODUCTION 103 TABLE 58 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 103 9.2 URBAN AREAS 103 9.2.1 RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT 103 TABLE 59 DIGITAL PHARMACY MARKET IN URBAN AREAS, BY REGION, 2020–2027 (USD MILLION) 104 9.3 RURAL AREAS 104 9.3.1 GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS 104 TABLE 60 DIGITAL PHARMACY MARKET IN RURAL AREAS, BY REGION, 2020–2027 (USD MILLION) 105 10 DIGITAL PHARMACY MARKET, BY REGION 106 10.1 INTRODUCTION 107 TABLE 61 DIGITAL PHARMACY MARKET, BY REGION, 2020–2027 (USD MILLION) 107 10.2 NORTH AMERICA 107 10.2.1 IMPACT OF COVID-19 ON THE NORTH AMERICAN DIGITAL PHARMACY MARKET 107 FIGURE 22 NORTH AMERICA: DIGITAL PHARMACY MARKET SNAPSHOT 108 TABLE 62 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109 TABLE 63 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 109 TABLE 64 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109 TABLE 65 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 110 TABLE 66 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 110 TABLE 67 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 110 TABLE 68 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 111 10.2.2 US 111 10.2.2.1 The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions 111 TABLE 69 US: KEY MACROINDICATORS 112 TABLE 70 US: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 112 TABLE 71 US: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 112 TABLE 72 US: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 113 TABLE 73 US: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 113 TABLE 74 US: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 113 TABLE 75 US: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 114 10.2.3 CANADA 114 10.2.3.1 Rising drug expenditures to propel market growth in Canada 114 TABLE 76 CANADA: KEY MACROINDICATORS 115 TABLE 77 CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 115 TABLE 78 CANADA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116 TABLE 79 CANADA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 116 TABLE 80 CANADA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 116 TABLE 81 CANADA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 117 TABLE 82 CANADA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 117 10.3 EUROPE 117 10.3.1 IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET 118 TABLE 83 EUROPE: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118 TABLE 84 EUROPE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 118 TABLE 85 EUROPE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119 TABLE 86 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 119 TABLE 87 EUROPE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 119 TABLE 88 EUROPE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 120 10.3.2 GERMANY 120 10.3.2.1 Germany is the fastest-growing market for digital pharmacies in Europe 120 TABLE 89 GERMANY: KEY MACROINDICATORS 121 TABLE 90 GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 121 TABLE 91 GERMANY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121 TABLE 92 GERMANY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 122 TABLE 93 GERMANY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 122 TABLE 94 GERMANY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 122 10.3.3 UK 123 10.3.3.1 Rising initiatives to improve the safety of digital pharmacies to boost the market growth 123 TABLE 95 UK: KEY MACROINDICATORS 124 TABLE 96 UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 124 TABLE 97 UK: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124 TABLE 98 UK: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 125 TABLE 99 UK: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 125 TABLE 100 UK: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 125 10.3.4 FRANCE 126 10.3.4.1 Rising geriatric population in the country to support market growth 126 TABLE 101 FRANCE: KEY MACROINDICATORS 126 TABLE 102 FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 126 TABLE 103 FRANCE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127 TABLE 104 FRANCE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 127 TABLE 105 FRANCE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 127 TABLE 106 FRANCE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 128 10.3.5 ITALY 128 10.3.5.1 Growing burden of chronic diseases is driving the market growth in Italy 128 TABLE 107 ITALY: KEY MACROINDICATORS 129 TABLE 108 ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 129 TABLE 109 ITALY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129 TABLE 110 ITALY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 130 TABLE 111 ITALY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 130 TABLE 112 ITALY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 130 10.3.6 SPAIN 131 10.3.6.1 Increasing focus on improving the healthcare infrastructure in the country to support market growth 131 TABLE 113 SPAIN: KEY MACROINDICATORS 131 TABLE 114 SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 132 TABLE 115 SPAIN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132 TABLE 116 SPAIN: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 132 TABLE 117 SPAIN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 133 TABLE 118 SPAIN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 133 10.3.7 ROE 133 TABLE 119 ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 134 TABLE 120 ROE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134 TABLE 121 ROE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 122 ROE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 135 TABLE 123 ROE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 135 10.4 ASIA PACIFIC 136 10.4.1 IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET 136 FIGURE 23 ASIA PACIFIC: DIGITAL PHARMACY MARKET SNAPSHOT 137 TABLE 124 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138 TABLE 125 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138 TABLE 126 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 138 TABLE 127 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 139 10.4.2 CHINA 139 10.4.2.1 Increasing consumer demand for OTC products to drive the market for digital pharmacy in China 139 TABLE 128 CHINA: KEY MACROINDICATORS 140 TABLE 129 CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140 TABLE 130 CHINA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 140 TABLE 131 CHINA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 141 10.4.3 JAPAN 141 10.4.3.1 Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan 141 TABLE 132 JAPAN: KEY MACROINDICATORS 142 TABLE 133 JAPAN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142 TABLE 134 JAPAN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 142 TABLE 135 JAPAN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 143 10.4.4 INDIA 143 10.4.4.1 Favorable government initiatives and high density of rural population to support market growth in India 143 TABLE 136 INDIA: KEY MACROINDICATORS 144 TABLE 137 INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 144 TABLE 138 INDIA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 144 TABLE 139 INDIA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 140 INDIA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 145 TABLE 141 INDIA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 145 10.4.5 REST OF ASIA PACIFIC 146 TABLE 142 ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 146 TABLE 143 ROAPAC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 147 TABLE 144 ROAPAC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 147 TABLE 145 ROAPAC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 147 10.5 LATIN AMERICA 148 10.5.1 GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM 148 10.5.1.1 Impact of COVID-19 on the Latin American digital pharmacy market 148 TABLE 146 LATIN AMERICA: KEY MACROINDICATORS 149 TABLE 147 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 149 TABLE 148 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149 TABLE 149 LATIN AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 150 TABLE 150 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 150 TABLE 151 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 150 10.6 MIDDLE EAST & AFRICA 151 10.6.1 INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA 151 10.6.1.1 Impact of COVID-19 on the Middle East & Africa digital pharmacy market 152 TABLE 152 MEA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 152 TABLE 153 MEA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152 TABLE 154 MEA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 153 TABLE 155 MEA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 153 TABLE 156 MEA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 153 11 COMPETITIVE LANDSCAPE 154 11.1 OVERVIEW 154 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 154 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PHARMACY MARKET 154 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 155 11.4 MARKET RANKING 156 FIGURE 24 US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021 156 11.5 COMPETITIVE BENCHMARKING 157 11.5.1 OVERALL COMPANY FOOTPRINT 157 TABLE 157 OVERALL COMPANY FOOTPRINT 157 11.5.2 COMPANY DRUG TYPE FOOTPRINT 157 TABLE 158 COMPANY DRUG TYPE FOOTPRINT 157 11.5.3 COMPANY PRODUCT FOOTPRINT 158 TABLE 159 COMPANY PRODUCT FOOTPRINT 158 11.5.4 COMPANY PLATFORM FOOTPRINT 158 TABLE 160 COMPANY PLATFORM FOOTPRINT 158 11.5.5 COMPANY REGIONAL FOOTPRINT 159 TABLE 161 COMPANY REGIONAL FOOTPRINT 159 TABLE 162 DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES 159 11.6 COMPETITIVE LEADERSHIP MAPPING 160 11.6.1 STARS 160 11.6.2 EMERGING LEADERS 160 11.6.3 PERVASIVE PLAYERS 160 11.6.4 PARTICIPANTS 160 FIGURE 25 DIGITAL PHARMACY MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021 161 11.7 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES 162 11.7.1 PROGRESSIVE COMPANIES 162 11.7.2 STARTING BLOCKS 162 11.7.3 RESPONSIVE COMPANIES 162 11.7.4 DYNAMIC COMPANIES 162 FIGURE 26 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET 163 11.8 COMPETITIVE SITUATIONS AND TRENDS 164 11.8.1 PRODUCT/SERVICE UPGRADES 164 11.8.2 DEALS 165 11.8.3 OTHER DEVELOPMENTS 166 12 COMPANY PROFILES 167 12.1 KEY PLAYERS 167 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 CVS HEALTH 167 TABLE 163 CVS HEALTH: BUSINESS OVERVIEW 167 FIGURE 27 CVS HEALTH: COMPANY SNAPSHOT (2021) 168 12.1.2 CIGNA 170 TABLE 164 CIGNA: BUSINESS OVERVIEW 170 FIGURE 28 CIGNA: COMPANY SNAPSHOT (2021) 171 12.1.3 OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP) 173 TABLE 165 OPTUM, INC.: BUSINESS OVERVIEW 173 FIGURE 29 OPTUM, INC.: COMPANY SNAPSHOT (2021) 174 12.1.4 WALGREEN CO. 176 TABLE 166 WALGREEN CO.: BUSINESS OVERVIEW 176 FIGURE 30 WALGREEN CO.: COMPANY SNAPSHOT (2021) 176 12.1.5 WALMART INC. 179 TABLE 167 WALMART INC.: BUSINESS OVERVIEW 179 FIGURE 31 WALMART INC.: COMPANY SNAPSHOT (2021) 180 12.1.6 THE KROGER CO. 182 TABLE 168 THE KROGER CO.: BUSINESS OVERVIEW 182 FIGURE 32 THE KROGER CO.: COMPANY SNAPSHOT (2020) 182 12.1.7 GIANT EAGLE, INC. 185 TABLE 169 GIANT EAGLE, INC.: BUSINESS OVERVIEW 185 12.1.8 AMAZON.COM, INC. 186 TABLE 170 AMAZON.COM, INC.: BUSINESS OVERVIEW 186 FIGURE 33 AMAZON.COM, INC.: COMPANY SNAPSHOT (2020) 187 12.1.9 PHARMEASY 190 TABLE 171 PHARMEASY: BUSINESS OVERVIEW 190 12.1.10 APEX PHARMACY 192 TABLE 172 APEX PHARMACY: BUSINESS OVERVIEW 192 12.1.11 APOLLO PHARMACY 194 TABLE 173 APOLLO PHARMACY: BUSINESS OVERVIEW 194 FIGURE 34 APOLLO HOSPITAL: COMPANY SNAPSHOT (2021) 195 12.1.12 RITE AID CORP 197 TABLE 174 RITE AID CORP.: BUSINESS OVERVIEW 197 FIGURE 35 RITE AID CORP.: COMPANY SNAPSHOT (2021) 197 12.1.13 COSTCO WHOLESALE CORPORATION 200 TABLE 175 COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW 200 FIGURE 36 COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021) 200 12.2 OTHER KEY PLAYERS 203 12.2.1 SHOP-APOTHEKE.COM 203 12.2.2 NETMEDS.COM 204 12.2.3 DOCMORRIS 205 12.2.4 TATA 1MG 206 12.2.5 LLOYDSPHARMACY 207 12.2.6 GOODRX, INC. 208 12.2.7 HEALTHWAREHOUSE.COM 209 12.2.8 TELUS HEALTH 210 12.2.9 PHARMEX DIRECT INC. 210 12.2.10 HIMS & HERS HEALTH, INC. 211 12.2.11 RO PHARMACY 211 12.2.12 RX OUTREACH 212 12.2.13 THE INDEPENDENT PHARMACY 213 12.2.14 REXALL PHARMACY GROUP ULC 214 12.2.15 NORTHWESTPHARMACY.COM 215 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 217 13.1 DISCUSSION GUIDE 217 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221 13.3 AVAILABLE CUSTOMIZATIONS 223 13.4 RELATED REPORTS 223 13.5 AUTHOR DETAILS 224
SummaryThe digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. Table of Contents1 INTRODUCTION 271.1 OBJECTIVES OF THE STUDY 27 1.2 MARKET DEFINITION 27 1.2.1 DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS 27 1.3 MARKET SCOPE 28 1.3.1 MARKETS COVERED 28 FIGURE 1 DIGITAL PHARMACY MARKET 28 1.3.2 YEARS CONSIDERED FOR THE STUDY 29 1.4 CURRENCY 29 1.5 LIMITATIONS 29 1.5.1 SCOPE-RELATED LIMITATIONS 29 1.6 STAKEHOLDERS 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH DATA 30 FIGURE 2 RESEARCH DESIGN 30 2.1.1 SECONDARY DATA 31 2.1.1.1 Key data from secondary sources 32 2.1.2 PRIMARY RESEARCH 32 2.1.2.1 Key industry insights 33 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34 2.2 MARKET ESTIMATION 34 2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 34 2.2.2 APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION 35 FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 36 FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36 FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH 37 2.2.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION 38 FIGURE 7 DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH 38 2.2.4 GROWTH FORECAST 38 FIGURE 8 IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR 39 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39 2.3 MARKET DATA ESTIMATION AND TRIANGULATION 40 FIGURE 10 DATA TRIANGULATION METHODOLOGY 40 2.4 ASSUMPTIONS FOR THE STUDY 41 2.5 LIMITATIONS 41 2.6 RISK ASSESSMENT 42 TABLE 1 RISK ASSESSMENT: DIGITAL PHARMACY MARKET 42 3 EXECUTIVE SUMMARY 43 FIGURE 11 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION) 43 FIGURE 12 DIGITAL PHARMACY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 44 FIGURE 13 DIGITAL PHARMACY MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION) 44 FIGURE 14 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2022 VS. 2027 (USD MILLION) 45 FIGURE 15 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2022 VS. 2027 (USD MILLION) 46 FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET 47 4 PREMIUM INSIGHTS 48 4.1 DIGITAL PHARMACY MARKET OVERVIEW 48 FIGURE 17 GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH 48 4.2 DIGITAL PHARMACY MARKET, BY PRODUCT 49 FIGURE 18 MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PHARMACY MARKET IN 2021 49 4.3 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG & COUNTRY (2021) 49 FIGURE 19 PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021 49 4.4 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET 50 FIGURE 20 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 50 4.5 MARKET DYNAMICS 51 FIGURE 21 DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 4.5.1 DRIVERS 52 4.5.1.1 Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic 52 TABLE 2 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022) 52 4.5.1.2 Consolidation in the market and partnerships 53 4.5.1.3 Growing geriatric population 53 TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION) 53 4.5.2 RESTRAINTS 54 4.5.2.1 Growing number of illegal pharmacies 54 4.5.2.2 Risk of counterfeit drugs 54 4.5.2.3 Increased risk of drug abuse 55 4.5.3 OPPORTUNITIES 55 4.5.3.1 Emerging markets 55 4.5.3.2 Benefits of E-commerce 56 4.5.4 CHALLENGES 56 4.5.4.1 Challenges for patients relying on pharmacists for clinical support 56 4.5.4.2 Lack of strong national laws worldwide 57 4.5.4.3 Security and privacy concerns 58 4.6 VALUE CHAIN ANALYSIS 59 4.7 ECOSYSTEM ANALYSIS 60 4.8 PORTER’S FIVE FORCES ANALYSIS 60 TABLE 4 DIGITAL PHARMACY MARKET: PORTER’S FIVE FORCES ANALYSIS 60 4.8.1 INTENSITY OF COMPETITIVE RIVALRY 61 4.8.2 BARGAINING POWER OF SUPPLIERS 61 4.8.3 BARGAINING POWER OF BUYERS 61 4.8.4 THREAT FROM SUBSTITUTES 61 4.8.5 THREAT FROM NEW ENTRANTS 61 4.9 PRICING & REIMBURSEMENT ANALYSIS 61 TABLE 5 COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS 62 4.10 TECHNOLOGY ANALYSIS 62 4.10.1 MACHINE LEARNING 62 4.10.2 INTERNET OF THINGS 63 4.10.3 BLOCKCHAIN 63 4.10.4 CLOUD COMPUTING 63 4.11 INDUSTRY TRENDS 63 4.11.1 ONLINE PRESCRIPTION REFILL 63 4.11.2 VIRTUAL HEALTHCARE SERVICES 64 4.11.3 DIGITAL HEALTH DIAGNOSTIC TOOLS 64 4.12 KEY CONFERENCES & EVENTS IN 2021–2022 65 4.13 REGULATORY ANALYSIS 65 4.13.1 NORTH AMERICA 65 4.13.1.1 US 65 4.13.1.2 Canada 66 4.13.2 EUROPE 66 4.13.3 ASIA PACIFIC 67 4.13.4 REST OF THE WORLD 67 TABLE 6 APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE TO CONTROL MEDICINAL PRODUCT ONLINE SALES 67 4.14 CASE STUDIES 68 4.14.1 MAGENTO 2 WEB APP MODERNIZATION 68 4.14.1.1 Use Case 1: Need to Revamp Online Store 68 4.14.2 WALMART REACT NATIVE PHARMACY 69 4.14.2.1 Use Case 2: Need to Rebuild Pharmacy App 69 4.15 IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET 69 5 DIGITAL PHARMACY MARKET, BY DRUG TYPE 70 5.1 INTRODUCTION 71 TABLE 7 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 71 5.2 PRESCRIPTION MEDICINES 71 5.2.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION 71 TABLE 8 DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020–2027 (USD MILLION) 72 TABLE 9 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION) 72 TABLE 10 EUROPE: DIGITAL PHARMACY MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION) 73 5.3 OVER-THE-COUNTER PRODUCTS 73 5.3.1 EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH 73 TABLE 11 DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 74 TABLE 12 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 74 TABLE 13 EUROPE: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 75 6 DIGITAL PHARMACY MARKET, BY PRODUCT 76 6.1 INTRODUCTION 77 TABLE 14 DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 77 6.2 MEDICINES & TREATMENTS 77 TABLE 15 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 78 TABLE 16 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 17 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 18 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 79 TABLE 19 DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 79 6.2.1 DIABETES CARE 79 6.2.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments 79 TABLE 20 DIGITAL PHARMACY MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 80 6.2.2 HEART CARE 80 6.2.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments 80 TABLE 21 DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 81 6.2.3 ONCOLOGY 81 6.2.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment 81 TABLE 22 DIGITAL PHARMACY MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 81 6.2.3.2 Other medicines & treatments 82 TABLE 23 DIGITAL PHARMACY MARKET FOR OTHER MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION) 82 6.3 PERSONAL CARE PRODUCTS 82 6.3.1 GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH 82 TABLE 24 DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 83 TABLE 25 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 83 TABLE 26 EUROPE: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 83 TABLE 27 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 84 6.4 VITAMINS & SUPPLEMENTS 84 6.4.1 GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH 84 TABLE 28 DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020–2027 (USD MILLION) 85 TABLE 29 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 30 EUROPE: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 85 TABLE 31 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 86 6.5 OTHER PRODUCTS 86 TABLE 32 DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 86 TABLE 33 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 TABLE 34 EUROPE: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 TABLE 35 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 87 7 DIGITAL PHARMACY MARKET, BY PLATFORM 88 7.1 INTRODUCTION 89 TABLE 36 DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 89 7.2 APPS 89 7.2.1 ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL DRIVE THE DEMAND FOR APPS 89 TABLE 37 DIGITAL PHARMACY APPS MARKET, BY REGION, 2020–2027 (USD MILLION) 90 TABLE 38 NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90 TABLE 39 EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90 TABLE 40 ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91 7.3 WEBSITES 91 7.3.1 PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH 91 TABLE 41 DIGITAL PHARMACY WEBSITES MARKET, BY REGION, 2020–2027 (USD MILLION) 92 TABLE 42 NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 TABLE 43 EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 TABLE 44 ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93 8 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL 94 8.1 INTRODUCTION 95 TABLE 45 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 95 8.2 CAPTIVE 95 8.2.1 FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS— KEY FACTORS DRIVING MARKET GROWTH 95 TABLE 46 DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY REGION, 2020–2027 (USD MILLION) 96 TABLE 47 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 48 EUROPE: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 96 TABLE 49 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 97 8.3 FRANCHISE 97 8.3.1 GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH 97 TABLE 50 DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY REGION, 2020–2027 (USD MILLION) 98 TABLE 51 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 98 TABLE 52 EUROPE: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 98 TABLE 53 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 99 8.4 AGGREGATOR 99 8.4.1 QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH 99 TABLE 54 DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY REGION, 2020–2027 (USD MILLION) 100 TABLE 55 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 100 TABLE 56 EUROPE: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 100 TABLE 57 ASIA PACIFIC: DIGITAL PHARMACY MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION) 101 9 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE 102 9.1 INTRODUCTION 103 TABLE 58 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 103 9.2 URBAN AREAS 103 9.2.1 RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT 103 TABLE 59 DIGITAL PHARMACY MARKET IN URBAN AREAS, BY REGION, 2020–2027 (USD MILLION) 104 9.3 RURAL AREAS 104 9.3.1 GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS 104 TABLE 60 DIGITAL PHARMACY MARKET IN RURAL AREAS, BY REGION, 2020–2027 (USD MILLION) 105 10 DIGITAL PHARMACY MARKET, BY REGION 106 10.1 INTRODUCTION 107 TABLE 61 DIGITAL PHARMACY MARKET, BY REGION, 2020–2027 (USD MILLION) 107 10.2 NORTH AMERICA 107 10.2.1 IMPACT OF COVID-19 ON THE NORTH AMERICAN DIGITAL PHARMACY MARKET 107 FIGURE 22 NORTH AMERICA: DIGITAL PHARMACY MARKET SNAPSHOT 108 TABLE 62 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109 TABLE 63 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 109 TABLE 64 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109 TABLE 65 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 110 TABLE 66 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 110 TABLE 67 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 110 TABLE 68 NORTH AMERICA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 111 10.2.2 US 111 10.2.2.1 The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions 111 TABLE 69 US: KEY MACROINDICATORS 112 TABLE 70 US: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 112 TABLE 71 US: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 112 TABLE 72 US: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 113 TABLE 73 US: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 113 TABLE 74 US: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 113 TABLE 75 US: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 114 10.2.3 CANADA 114 10.2.3.1 Rising drug expenditures to propel market growth in Canada 114 TABLE 76 CANADA: KEY MACROINDICATORS 115 TABLE 77 CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 115 TABLE 78 CANADA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116 TABLE 79 CANADA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 116 TABLE 80 CANADA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 116 TABLE 81 CANADA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 117 TABLE 82 CANADA: DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION) 117 10.3 EUROPE 117 10.3.1 IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET 118 TABLE 83 EUROPE: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118 TABLE 84 EUROPE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 118 TABLE 85 EUROPE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119 TABLE 86 EUROPE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 119 TABLE 87 EUROPE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 119 TABLE 88 EUROPE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 120 10.3.2 GERMANY 120 10.3.2.1 Germany is the fastest-growing market for digital pharmacies in Europe 120 TABLE 89 GERMANY: KEY MACROINDICATORS 121 TABLE 90 GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 121 TABLE 91 GERMANY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121 TABLE 92 GERMANY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 122 TABLE 93 GERMANY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 122 TABLE 94 GERMANY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 122 10.3.3 UK 123 10.3.3.1 Rising initiatives to improve the safety of digital pharmacies to boost the market growth 123 TABLE 95 UK: KEY MACROINDICATORS 124 TABLE 96 UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 124 TABLE 97 UK: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124 TABLE 98 UK: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 125 TABLE 99 UK: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 125 TABLE 100 UK: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 125 10.3.4 FRANCE 126 10.3.4.1 Rising geriatric population in the country to support market growth 126 TABLE 101 FRANCE: KEY MACROINDICATORS 126 TABLE 102 FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 126 TABLE 103 FRANCE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127 TABLE 104 FRANCE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 127 TABLE 105 FRANCE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 127 TABLE 106 FRANCE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 128 10.3.5 ITALY 128 10.3.5.1 Growing burden of chronic diseases is driving the market growth in Italy 128 TABLE 107 ITALY: KEY MACROINDICATORS 129 TABLE 108 ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 129 TABLE 109 ITALY: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129 TABLE 110 ITALY: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 130 TABLE 111 ITALY: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 130 TABLE 112 ITALY: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 130 10.3.6 SPAIN 131 10.3.6.1 Increasing focus on improving the healthcare infrastructure in the country to support market growth 131 TABLE 113 SPAIN: KEY MACROINDICATORS 131 TABLE 114 SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 132 TABLE 115 SPAIN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132 TABLE 116 SPAIN: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 132 TABLE 117 SPAIN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 133 TABLE 118 SPAIN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 133 10.3.7 ROE 133 TABLE 119 ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 134 TABLE 120 ROE: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134 TABLE 121 ROE: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 135 TABLE 122 ROE: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 135 TABLE 123 ROE: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 135 10.4 ASIA PACIFIC 136 10.4.1 IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET 136 FIGURE 23 ASIA PACIFIC: DIGITAL PHARMACY MARKET SNAPSHOT 137 TABLE 124 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138 TABLE 125 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 138 TABLE 126 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 138 TABLE 127 ASIA PACIFIC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 139 10.4.2 CHINA 139 10.4.2.1 Increasing consumer demand for OTC products to drive the market for digital pharmacy in China 139 TABLE 128 CHINA: KEY MACROINDICATORS 140 TABLE 129 CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140 TABLE 130 CHINA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 140 TABLE 131 CHINA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 141 10.4.3 JAPAN 141 10.4.3.1 Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan 141 TABLE 132 JAPAN: KEY MACROINDICATORS 142 TABLE 133 JAPAN: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142 TABLE 134 JAPAN: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 142 TABLE 135 JAPAN: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 143 10.4.4 INDIA 143 10.4.4.1 Favorable government initiatives and high density of rural population to support market growth in India 143 TABLE 136 INDIA: KEY MACROINDICATORS 144 TABLE 137 INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 144 TABLE 138 INDIA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 144 TABLE 139 INDIA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 145 TABLE 140 INDIA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 145 TABLE 141 INDIA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 145 10.4.5 REST OF ASIA PACIFIC 146 TABLE 142 ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 146 TABLE 143 ROAPAC: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 147 TABLE 144 ROAPAC: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 147 TABLE 145 ROAPAC: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 147 10.5 LATIN AMERICA 148 10.5.1 GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM 148 10.5.1.1 Impact of COVID-19 on the Latin American digital pharmacy market 148 TABLE 146 LATIN AMERICA: KEY MACROINDICATORS 149 TABLE 147 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 149 TABLE 148 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149 TABLE 149 LATIN AMERICA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 150 TABLE 150 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 150 TABLE 151 LATIN AMERICA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 150 10.6 MIDDLE EAST & AFRICA 151 10.6.1 INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA 151 10.6.1.1 Impact of COVID-19 on the Middle East & Africa digital pharmacy market 152 TABLE 152 MEA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION) 152 TABLE 153 MEA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152 TABLE 154 MEA: DIGITAL PHARMACY MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION) 153 TABLE 155 MEA: DIGITAL PHARMACY MARKET, BY PLATFORM, 2020–2027 (USD MILLION) 153 TABLE 156 MEA: DIGITAL PHARMACY MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION) 153 11 COMPETITIVE LANDSCAPE 154 11.1 OVERVIEW 154 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 154 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PHARMACY MARKET 154 11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 155 11.4 MARKET RANKING 156 FIGURE 24 US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021 156 11.5 COMPETITIVE BENCHMARKING 157 11.5.1 OVERALL COMPANY FOOTPRINT 157 TABLE 157 OVERALL COMPANY FOOTPRINT 157 11.5.2 COMPANY DRUG TYPE FOOTPRINT 157 TABLE 158 COMPANY DRUG TYPE FOOTPRINT 157 11.5.3 COMPANY PRODUCT FOOTPRINT 158 TABLE 159 COMPANY PRODUCT FOOTPRINT 158 11.5.4 COMPANY PLATFORM FOOTPRINT 158 TABLE 160 COMPANY PLATFORM FOOTPRINT 158 11.5.5 COMPANY REGIONAL FOOTPRINT 159 TABLE 161 COMPANY REGIONAL FOOTPRINT 159 TABLE 162 DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES 159 11.6 COMPETITIVE LEADERSHIP MAPPING 160 11.6.1 STARS 160 11.6.2 EMERGING LEADERS 160 11.6.3 PERVASIVE PLAYERS 160 11.6.4 PARTICIPANTS 160 FIGURE 25 DIGITAL PHARMACY MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021 161 11.7 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES 162 11.7.1 PROGRESSIVE COMPANIES 162 11.7.2 STARTING BLOCKS 162 11.7.3 RESPONSIVE COMPANIES 162 11.7.4 DYNAMIC COMPANIES 162 FIGURE 26 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET 163 11.8 COMPETITIVE SITUATIONS AND TRENDS 164 11.8.1 PRODUCT/SERVICE UPGRADES 164 11.8.2 DEALS 165 11.8.3 OTHER DEVELOPMENTS 166 12 COMPANY PROFILES 167 12.1 KEY PLAYERS 167 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 12.1.1 CVS HEALTH 167 TABLE 163 CVS HEALTH: BUSINESS OVERVIEW 167 FIGURE 27 CVS HEALTH: COMPANY SNAPSHOT (2021) 168 12.1.2 CIGNA 170 TABLE 164 CIGNA: BUSINESS OVERVIEW 170 FIGURE 28 CIGNA: COMPANY SNAPSHOT (2021) 171 12.1.3 OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP) 173 TABLE 165 OPTUM, INC.: BUSINESS OVERVIEW 173 FIGURE 29 OPTUM, INC.: COMPANY SNAPSHOT (2021) 174 12.1.4 WALGREEN CO. 176 TABLE 166 WALGREEN CO.: BUSINESS OVERVIEW 176 FIGURE 30 WALGREEN CO.: COMPANY SNAPSHOT (2021) 176 12.1.5 WALMART INC. 179 TABLE 167 WALMART INC.: BUSINESS OVERVIEW 179 FIGURE 31 WALMART INC.: COMPANY SNAPSHOT (2021) 180 12.1.6 THE KROGER CO. 182 TABLE 168 THE KROGER CO.: BUSINESS OVERVIEW 182 FIGURE 32 THE KROGER CO.: COMPANY SNAPSHOT (2020) 182 12.1.7 GIANT EAGLE, INC. 185 TABLE 169 GIANT EAGLE, INC.: BUSINESS OVERVIEW 185 12.1.8 AMAZON.COM, INC. 186 TABLE 170 AMAZON.COM, INC.: BUSINESS OVERVIEW 186 FIGURE 33 AMAZON.COM, INC.: COMPANY SNAPSHOT (2020) 187 12.1.9 PHARMEASY 190 TABLE 171 PHARMEASY: BUSINESS OVERVIEW 190 12.1.10 APEX PHARMACY 192 TABLE 172 APEX PHARMACY: BUSINESS OVERVIEW 192 12.1.11 APOLLO PHARMACY 194 TABLE 173 APOLLO PHARMACY: BUSINESS OVERVIEW 194 FIGURE 34 APOLLO HOSPITAL: COMPANY SNAPSHOT (2021) 195 12.1.12 RITE AID CORP 197 TABLE 174 RITE AID CORP.: BUSINESS OVERVIEW 197 FIGURE 35 RITE AID CORP.: COMPANY SNAPSHOT (2021) 197 12.1.13 COSTCO WHOLESALE CORPORATION 200 TABLE 175 COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW 200 FIGURE 36 COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021) 200 12.2 OTHER KEY PLAYERS 203 12.2.1 SHOP-APOTHEKE.COM 203 12.2.2 NETMEDS.COM 204 12.2.3 DOCMORRIS 205 12.2.4 TATA 1MG 206 12.2.5 LLOYDSPHARMACY 207 12.2.6 GOODRX, INC. 208 12.2.7 HEALTHWAREHOUSE.COM 209 12.2.8 TELUS HEALTH 210 12.2.9 PHARMEX DIRECT INC. 210 12.2.10 HIMS & HERS HEALTH, INC. 211 12.2.11 RO PHARMACY 211 12.2.12 RX OUTREACH 212 12.2.13 THE INDEPENDENT PHARMACY 213 12.2.14 REXALL PHARMACY GROUP ULC 214 12.2.15 NORTHWESTPHARMACY.COM 215 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 13 APPENDIX 217 13.1 DISCUSSION GUIDE 217 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221 13.3 AVAILABLE CUSTOMIZATIONS 223 13.4 RELATED REPORTS 223 13.5 AUTHOR DETAILS 224
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(薬学的薬物)の最新刊レポートMarketsandMarkets社のその他分野での最新刊レポート
本レポートと同じKEY WORD(pharmacy)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |